BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22525692)

  • 1. [Glucokinase gene mutation as a causative factor of permanent neonatal diabetes mellitus].
    Wajda-Cuszlag M; Witkowski D; Piontek E; Wysocka-Mincewicz M; Borowiec M; Młynarski W; Szalecki M
    Pediatr Endocrinol Diabetes Metab; 2012; 18(1):45-7. PubMed ID: 22525692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The usage of the personal insulin pump for treatment of a 7 week infant with neonatal diabetes mellitus].
    Mysliwiec M; Balcerska A; Bautembach-Minkowska J; Malecki MT; Nazim J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):296-9. PubMed ID: 17239309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permanent neonatal diabetes caused by a homozygous nonsense mutation in the glucokinase gene.
    Rubio-Cabezas O; Díaz González F; Aragonés A; Argente J; Campos-Barros A
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):245-9. PubMed ID: 18298419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age.
    Odem J; Munzinger E; Violand S; Van Morlan A; Rife D; Bachrach B
    Pediatr Diabetes; 2009 Dec; 10(8):550-3. PubMed ID: 19515026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene.
    Bennett K; James C; Mutair A; Al-Shaikh H; Sinani A; Hussain K
    Pediatr Diabetes; 2011 May; 12(3 Pt 1):192-6. PubMed ID: 21518409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review on monogenic diabetes.
    Steck AK; Winter WE
    Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):252-8. PubMed ID: 21844708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
    Gloyn AL
    Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
    Massa O; Iafusco D; D'Amato E; Gloyn AL; Hattersley AT; Pasquino B; Tonini G; Dammacco F; Zanette G; Meschi F; Porzio O; Bottazzo G; Crinó A; Lorini R; Cerutti F; Vanelli M; Barbetti F;
    Hum Mutat; 2005 Jan; 25(1):22-7. PubMed ID: 15580558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A family with novel homozygous deletion mutation (c.1255delT; p.Phe419Serfs*12) in the glucokinase gene, which is a rare cause of permanent neonatal diabetes mellitus.
    Bolu S; Eröz R; Doğan M; Arslanoğlu İ; Uzun H; Timur F
    Turk Pediatri Ars; 2020; 55(4):434-437. PubMed ID: 33414663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
    Bremer AA; Ranadive S; Lustig RH
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.
    Njølstad PR; Sagen JV; Bjørkhaug L; Odili S; Shehadeh N; Bakry D; Sarici SU; Alpay F; Molnes J; Molven A; Søvik O; Matschinsky FM
    Diabetes; 2003 Nov; 52(11):2854-60. PubMed ID: 14578306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.
    Rica I; Luzuriaga C; Pérez de Nanclares G; Estalella I; Aragonés A; Barrio R; Bilbao JR; Carlés C; Fernández C; Fernández JM; Fernández-Rebollo E; Gastaldo E; Giralt P; Gomez Vida JM; Gutiérrez A; López Siguero JP; Martínez-Aedo MJ; Muñoz M; Prieto J; Rodrigo J; Vargas F; Castano L
    Diabet Med; 2007 Jul; 24(7):707-13. PubMed ID: 17490422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.
    Molven A; Ringdal M; Nordbø AM; Raeder H; Støy J; Lipkind GM; Steiner DF; Philipson LH; Bergmann I; Aarskog D; Undlien DE; Joner G; Søvik O; ; Bell GI; Njølstad PR
    Diabetes; 2008 Apr; 57(4):1131-5. PubMed ID: 18192540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
    Mohamadi A; Clark LM; Lipkin PH; Mahone EM; Wodka EL; Plotnick LP
    Pediatr Diabetes; 2010 May; 11(3):203-7. PubMed ID: 19686306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucokinase gene abnormalities in maturity-onset diabetes of the young (MODY) and late-onset NIDDM].
    Odawara M
    Nihon Rinsho; 1994 Oct; 52(10):2580-6. PubMed ID: 7983782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent neonatal diabetes mellitus due to a C96Y heterozygous mutation in the insulin gene. A case report.
    Ahamed A; Unnikrishnan AG; Pendsey SS; Nampoothiri S; Bhavani N; Praveen VP; Kumar H; Jayakumar RV; Nair V; Ellard S; Edghill EL
    JOP; 2008 Nov; 9(6):715-8. PubMed ID: 18981553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical heterogeneity in the same generation of siblings with GCK/MODY 2.
    Maltoni G; Zucchini S; Martini AL; Marasco E; Mantovani V; Pession A
    Diabetes Res Clin Pract; 2015 Jan; 107(1):e1-3. PubMed ID: 25467089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families.
    Velho G; Blanché H; Vaxillaire M; Bellanné-Chantelot C; Pardini VC; Timsit J; Passa P; Deschamps I; Robert JJ; Weber IT; Marotta D; Pilkis SJ; Lipkind GM; Bell GI; Froguel P
    Diabetologia; 1997 Feb; 40(2):217-24. PubMed ID: 9049484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
    Gloyn AL; Pearson ER; Antcliff JF; Proks P; Bruining GJ; Slingerland AS; Howard N; Srinivasan S; Silva JM; Molnes J; Edghill EL; Frayling TM; Temple IK; Mackay D; Shield JP; Sumnik Z; van Rhijn A; Wales JK; Clark P; Gorman S; Aisenberg J; Ellard S; Njølstad PR; Ashcroft FM; Hattersley AT
    N Engl J Med; 2004 Apr; 350(18):1838-49. PubMed ID: 15115830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.